SEC. 4554. IMPROVEMENTS <<NOTE: 42 USC 1395u note.>> IN ADMINISTRATION
OF LABORATORY TESTS BENEFIT.
(a) Selection of Regional Carriers.--
(1) In general.--The Secretary of Health and Human Services
(in this section referred to as the ``Secretary'') shall--
(A) divide the United States into no more than 5
regions, and
(B) designate a single carrier for each such region,
for the purpose of payment of claims under part B of title XVIII
of the Social Security Act with respect to clinical diagnostic
laboratory tests furnished on or after such date (not later than
July 1, 1999) as the Secretary specifies.
(2) Designation.--In designating such carriers, the
Secretary shall consider, among other criteria--
(A) a carrier's timeliness, quality, and experience
in claims processing, and
[[Page 111 STAT. 461]]
(B) a carrier's capacity to conduct electronic data
interchange with laboratories and data matches with
other carriers.
(3) Single data resource.--The Secretary shall select one of
the designated carriers to serve as a central statistical
resource for all claims information relating to such clinical
diagnostic laboratory tests handled by all the designated
carriers under such part.
(4) Allocation of claims.--The allocation of claims for
clinical diagnostic laboratory tests to particular designated
carriers shall be based on whether a carrier serves the
geographic area where the laboratory specimen was collected or
other method specified by the Secretary.
(5) Secretarial exclusion.--Paragraph (1) shall not apply
with respect to clinical diagnostic laboratory tests furnished
by physician office laboratories if the Secretary determines
that such offices would be unduly burdened by the application of
billing responsibilities with respect to more than one carrier.
(b) Adoption of National Policies for Clinical Laboratory Tests
Benefit.--
(1) In general.--Not later than January 1, 1999, the
Secretary shall first adopt, consistent with paragraph (2),
national coverage and administrative policies for clinical
diagnostic laboratory tests under part B of title XVIII of the
Social Security Act, using a negotiated rulemaking process under
subchapter III of chapter 5 of title 5, United States Code.
(2) Considerations in design of national policies.--The
policies under paragraph (1) shall be designed to promote
program integrity and national uniformity and simplify
administrative requirements with respect to clinical diagnostic
laboratory tests payable under such part in connection with the
following:
(A) Beneficiary information required to be submitted
with each claim or order for laboratory tests.
(B) The medical conditions for which a laboratory
test is reasonable and necessary (within the meaning of
section 1862(a)(1)(A) of the Social Security Act).
(C) The appropriate use of procedure codes in
billing for a laboratory test, including the unbundling
of laboratory services.
(D) The medical documentation that is required by a
medicare contractor at the time a claim is submitted for
a laboratory test in accordance with section 1833(e) of
the Social Security Act.
(E) Recordkeeping requirements in addition to any
information required to be submitted with a claim,
including physicians' obligations regarding such
requirements.
(F) Procedures for filing claims and for providing
remittances by electronic media.
(G) Limitation on frequency of coverage for the same
tests performed on the same individual.
(3) Changes in laboratory policies pending adoption of
national policy.--During the period that begins on the date of
the enactment of this Act and ends on the date the Secretary
first implements national policies pursuant to regulations
promulgated under this subsection, a carrier under such
[[Page 111 STAT. 462]]
part may implement changes relating to requirements for the
submission of a claim for clinical diagnostic laboratory tests.
(4) Use of interim policies.--After the date the Secretary
first implements such national policies, the Secretary shall
permit any carrier to develop and implement interim policies of
the type described in paragraph (1), in accordance with
guidelines established by the Secretary, in cases in which a
uniform national policy has not been established under this
subsection and there is a demonstrated need for a policy to
respond to aberrant utilization or provision of unnecessary
tests. Except as the Secretary specifically permits, no policy
shall be implemented under this paragraph for a period of longer
than 2 years.
(5) Interim national policies.--After the date the Secretary
first designates regional carriers under subsection (a), the
Secretary shall establish a process under which designated
carriers can collectively develop and implement interim national
policies of the type described in paragraph (1). No such policy
shall be implemented under this paragraph for a period of longer
than 2 years.
(6) Biennial review process.--Not less often than once every
2 years, the Secretary shall solicit and review comments
regarding changes in the national policies established under
this subsection. As part of such biennial review process, the
Secretary shall specifically review and consider whether to
incorporate or supersede interim policies developed under
paragraph (4) or (5). Based upon such review, the Secretary may
provide for appropriate changes in the national policies
previously adopted under this subsection.
(7) Requirement and notice.--The Secretary shall ensure that
any policies adopted under paragraph (3), (4), or (5) shall
apply to all laboratory claims payable under part B of title
XVIII of the Social Security Act, and shall provide for advance
notice to interested parties and a 45-day period in which such
parties may submit comments on the proposed change.
(c) Inclusion of Laboratory Representative on Carrier Advisory
Committees.--The Secretary shall direct that any advisory committee
established by a carrier to advise such carrier with respect to coverage
and administrative policies under part B of title XVIII of the Social
Security Act shall include an individual to represent the independent
clinical laboratories and such other laboratories as the Secretary deems
appropriate. The Secretary shall consider recommendations from national
and local organizations that represent independent clinical laboratories
in such selection.
Sunday, December 9, 2018
1997 Balanced Budget Act, Section 4554: Uniform CMS Lab Claims Policies
https://www.gpo.gov/fdsys/pkg/PLAW-105publ33/html/PLAW-105publ33.htm
Labels:
4554,
bba,
negotiatedrulemaking
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.